Brief: Genmab Is Said To Near Deal To Buy Cancer Drugmaker Merus - Bloomberg News
Sept 28 (Reuters) - GENMAB IS SAID TO NEAR DEAL TO BUY CANCER DRUGMAKER MERUS - BLOOMBERG NEWS Source text: https://tinyurl.com/mrnyu447 Further company coverage: 2GH.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Says Orbis Investment Management Holds 4.99% Of Genmab Voting Rights As Of June 12
Brief: Genmab Announces Epcoritamab Monotherapy And Epcoritamab-Based Combination Regimens Demonstrate High Response Rates In Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Brief: Genmab Presents Epcore Fl-1 Data Showing Consistent Efficacy, Safety For Epcoritamab Combination
Brief: Genmab Says Orbis Investment Management Limited Holds 5.08% Of Genmab A/S As Of May 8, 2026
Genmab falls after 'uneventful' Q1, profit miss